Novartis Pharmaceuticals Canada Inc.
Occurred:
2024-12-12
Details Regarding the Identified Subject Matter
Subject matters
|
Details
|
Health, Industry
|
Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda.
|
Health
|
Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries
|